Tansoroxin’s treatment of the lower end of the urine tube.

Diarrhoea stones are a common urology disease, often leading to symptoms such as graft, blood urine, urination frequency, urinary acuteness and urinary pain, which greatly affect the quality of life of patients. In clinical treatments, Tansorosin hydrochloric acid, as a highly selective alpha1 receptor retardant, is widely used for the treatment of lower end stones of the urine tube, particularly for smaller sizes, which have significant therapeutic effects. Through personal clinical practice and literature, I have gained a deeper understanding and appreciation of the application of Tansorossin in the treatment of lower end stones.I. THE ROLE MECHANISM OF TANSOROSINTansorossin, through selective disruption of alpha1 receptors, especially alpha1d receptors, mainly acts as smooth muscles in the lower part of the urine tube, which relaxes the smooth muscles and reduces their tension and contraction. This mechanism of action can reduce the frequency of the perusal of the tube and, at the same time, increase the pressure above the rock and reduce the resistance below the rock, thus creating a pressure gradient around the rock and prompting it to come down below the rinse of the urine. This mechanism not only applies to the rock in the lower part of the urea tube, but is also often used to assist in the treatment of prostate growth and to improve the symptoms of urination difficulties by easing the stress of urinary smooth muscles.II. Clinical application of TansorossinIn the treatment of rock at the lower end of the urinary tube, Tasorossin is usually used as part of conservative treatment, especially for small stones less than 10 mm in diameter. Clinical practice has shown that through oral tanzosin, a combination of abundant drinking water and appropriate painkillers, can significantly increase the probability of the stones being released.In the details of the use of the drug, the Tanzarosin dose is usually 0.4 mg/day and should be taken after getting up in the morning in order to use gravity to facilitate the release of the quarries in a state of physical protonity and activity. Unlike the slow release tablets, non- slow release tablets should be used for the treatment of urinary-vegetation stones to ensure that drugs are used to maximum effect in a short period of time. In addition, Tansorossin ‘ s sessions are usually of a few weeks ‘ duration to ensure that they are fully functioning in the urine tube smoothing muscles and to facilitate the release of stones.III. THE EFFECTIVENESS AND SAFETY OF TANZOROSINA number of clinical studies have shown that Tansorossin has a significant therapeutic effect on the treatment of lower end stones of the urine tube. For example, a comparative test involving 88 cases of persons with lower sections of the urine tube showed that the success of the test group (the use of tasorosin) was significantly higher than that of the control group (the absence of tasorosin). This result further confirms the effectiveness of Tansorosin in the treatment of the lower end stones of the urine tube.However, Tansorossin is not without side effects. Common side effects include low blood pressure, dizziness, fatigue, most of which are associated with the expansion of vascular smooth muscles. Thus, in the use of Tansorossin, the assessment should be based on the patient ‘ s specific circumstances and the patient should be given a detailed account of the possible side effects before the drug is administered. In addition, for patients at higher risk of low blood pressure, the use of Tansorossin should be carefully used or avoided.The need for comprehensive treatmentAlthough Tansorossin has a significant therapeutic effect in the treatment of lower end stones in the urine tube, not all of them have been successfully discharged through drug treatment. In the case of larger or irregularly shaped stones or drug treatments, surgical treatments, such as in vitro-shock, urea lenses, etc., are usually considered.Therefore, individualized treatments should be developed when treating lower end stones of the urine tube, taking into account the specific circumstances of the patient. In addition to drug treatment, patients should be encouraged to drink more water, urinate more and exercise properly to facilitate the release of stones. At the same time, regular urine routines, B superps and abdominal tablets are regularly performed to monitor the release of stones and to adjust treatment programmes in a timely manner.Concluding remarksAs a highly selective alpha1 receptor retardant, Tansorosin has a significant healing effect and some safety in the treatment of the lower end stones of the urine tube. Tensoroxin has been able to significantly increase the probability of the rock being released by its own release, by reducing resistance through the smoothing of the lax tube. However, Tansorosin is not a panacea, and its efficacy is influenced by a variety of factors, such as the size, shape, location and individual differences of the patient. Therefore, when treating the lower end of the urine tube, a combination of factors should be taken into account and individualized treatments developed to achieve the best treatments.